PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

129 hedge funds and large institutions have $222M invested in Progenics Pharmaceuticals Inc in 2020 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 46 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

41% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 46

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
129
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$408K
Puts
$145K
Net Calls
Net Calls Change

Top Sellers

1 -$22.9M
2 -$20.1M
3 -$3.07M
4
Bank of America
Bank of America
North Carolina
-$1.74M
5
BlackRock
BlackRock
New York
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$46K
102
$45K
103
$37K
104
$36K
105
$29K
106
$26K
107
$25K
108
$18K
109
$16K
110
$14K
111
$14K
112
$9K
113
$7K
114
$5K
115
$4K
116
$3K
117
$3K
118
$2K
119
$2K
120
$2K
121
$1K
122
$1K
123
$1K
124
$1K
125
$1K